Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell TransplantationCristina Cunha, Agostinho Carvalho, Franco Aversa et al.|New England Journal of Medicine|2014Cited by 301
Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With LymphomaCorrado Tarella, Alessandro Rambaldi, Roberto Passera et al.|Journal of Clinical Oncology|2010Cited by 167
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL studyFranck Morschhauser, Loretta J. Nastoupil, James Lymp et al.|Nature Medicine|2024Cited by 127
Zygomycosis in Italy: A Survey of FIMUA-ECMM (Federazione Italiana Di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)Livio Pagano, O. Morelli, Caterina Giovanna Valentini et al.|Journal of Chemotherapy|2009Cited by 95
The lymphocyte to monocyte ratio improves the IPI‐risk definition of diffuse large B‐cell lymphoma when rituximab is added to chemotherapyAlessandro Rambaldi, Corrado Tarella, Cristina Boschini et al.|American Journal of Hematology|2013Cited by 65